TLDR
- Bloom Energy shares declined approximately 14% Thursday, retreating from the $346 record peak reached June 22.
- The decline occurred alongside news of a $1.7B investment project for deploying Bloom’s fuel cell technology in Nebius’ AI cloud operations.
- Clear Street maintained its Hold stance with a $290 target, suggesting the dip could present a strategic entry point.
- Hunterbrook’s short-seller analysis highlighted potential vulnerabilities in scandium procurement linked to Chinese supply chains.
- Analyst consensus remains at Moderate Buy with a collective price target averaging $285.45.
Shares of Bloom Energy experienced a significant downturn on Thursday, declining approximately 14%, with BE opening Friday trading at $205.94. This represents a considerable retreat from the company’s all-time high of $351.28 recorded on June 22.
Interestingly, this selloff occurred concurrently with the company’s announcement of a substantial $1.7 billion infrastructure investment from IDF and Oaktree, designated for deploying Bloom’s fuel cell systems across Nebius’ artificial intelligence cloud platform.
Clear Street maintained its Hold recommendation alongside a $290 price objective for BE shares, characterizing the recent downturn as potentially transitory rather than indicative of deteriorating business fundamentals.
“Pullback looks opportunistic,” the firm stated, highlighting the substantial differential between present trading levels and their established target.
The research firm identified three primary catalysts behind the stock’s weakness. Initially, AI-focused equities have broadly corrected since mid-June as market participants reassess whether current valuations accurately reflect anticipated capital expenditure levels for 2027 and 2028.
Additionally, emerging regulatory headwinds are introducing fresh uncertainty. New York established precedent as the initial state to implement a twelve-month moratorium on new data facilities exceeding 50 MW capacity, sparking apprehension regarding large-scale power infrastructure initiatives.
Finally, a critical research report issued by Hunterbrook highlighted potential vulnerabilities surrounding Bloom’s scandium procurement strategy. This rare earth element, essential for the company’s fuel cell production, predominantly originates from Chinese sources, where export licensing restrictions are reportedly intensifying.
Scandium Risk in Focus
Clear Street observed that apprehensions expressed by Bloom’s previous CFO primarily centered on late 2027 and 2028 timeframes, as the organization endeavors to establish a geographically diversified supply network. The short-focused analysis additionally questioned the viability of Bloom’s financing partnership with Brookfield while flagging potential timeline extensions affecting Wyoming and New Mexico installations.
Nevertheless, the firm preserved its neutral perspective, indicating that long-term business fundamentals remain sound.
Institutional Activity and Analyst Targets
Diversify Wealth Management initiated a fresh position during Q1, acquiring 6,579 shares worth approximately $891,000. Multiple additional institutional participants expanded their allocations throughout the quarter, with institutional ownership collectively representing 77.04% of BE stock.
Regarding insider transactions, Director John T. Chambers divested 55,000 shares in late May at an average execution price of $297.69, generating proceeds exceeding $16.3 million. Additionally, insider Aman Joshi sold 8,343 shares on July 1 at $300.37 per share.
Bloom’s latest quarterly financial results substantially exceeded analyst projections. The company delivered $0.44 earnings per share compared to the $0.12 consensus forecast, while revenue reached $751.05 million versus anticipated $539.94 million — representing year-over-year growth of 130.4%.
Susquehanna elevated its price objective to $298 with a “positive” designation on July 10. Robert W. Baird reaffirmed an “outperform” recommendation with a $310 target on July 9. The consensus average price objective currently registers at $250.41, suggesting 38.08% appreciation potential from Friday’s opening price.
BE’s 52-week range spans from $24.04 to $351.28.



